Tseng Hsiang Life Science Ltd.

The development of the biomarkers for translational medicine is a multistep process, and THLS can assist you in each step of process. Using our high-density arrays, researchers with modest budgets can screen for hundreds of potential cytokine biomarker candidates to find the most promising ones for further investigation, much faster than with traditional proteomic methods and at a fraction of the cost. Additionally, the antibodies used in our screening arrays are in most cases identical to those in our multiplex quantitative arrays and single target ELISA kits. This streamlines the workflow for biomarker development, making it faster and more affordable.

TSGH

Medical care and innovation research and development results

TSH biopharm corporation Itd

TSH’s vision is committed to improving the quality of life of patients with chronic diseases.

Prescription Medicine
TSH focuses on the development of patentable & high barrier specialty drugs with Pharmaco-economic profile. Our culture is working with honesty, integrity, entrepreneurship. We commit and contribute to society by integrating professional methods in science, our innovative mindset, and the team work spirit. Meanwhile, we are going to be a best partner for global pharmaceutical companies in drug developing & Asia marketing expert.

Comprehensive liquid biopsy
TSH liquid biopsy combines the CTC “CMxTM” platform with the next generation sequencing (NGS) “SMSEQTM” platform to form a complete cancer monitoring system.
It can provide a comprehensive liquid biopsy for heredity cancer risk assessment, high risk cancer patients’ screening, druggable genes detection and treatment monitoring.

TTBio Healthcare Inc.

Dental handpiece & Accessories:
Highspeed Handpiece
Lowspeed Handpiece
Micromotor
Maintenance Machine
Service Parts